| PROSIDION LIMITED Patent applications |
| Patent application number | Title | Published |
|---|
| 20120077793 | Compounds for the Treatment of Metabolic Disorders - The present invention is directed to therapeutic compounds which have activity as agonists of GPR119 and are useful for the treatment of metabolic disorders including type II diabetes. | 03-29-2012 |
| 20120059014 | Compounds for the Treatment of Metabolic Disorders - The present invention is directed to therapeutic compounds of the following formula (I) | 03-08-2012 |
| 20120040953 | Compounds for the Treatment of Metabolic Disorders - The present invention is directed to therapeutic compounds which have activity as agonists of GPR119 and are useful for the treatment of metabolic disorders including type II diabetes. | 02-16-2012 |
| 20110269734 | PIPERIDINYL GPCR AGONISTS - Compounds of formula (I):or pharmaceutically acceptable salts thereof, are GPCR agonists and are useful as for the treatment of diabetes and obesity. | 11-03-2011 |
| 20110230507 | Piperidine GPCR Agonists - Compounds of formula (I): or pharmaceutically acceptable salts thereof, are GPCR agonists and are useful as for the treatment of diabetes and obesity. | 09-22-2011 |
| 20110212939 | Heterocyclic GPCR Agonists - Compounds of formula (I) or pharmaceutically acceptable salts thereof, are GPCR (GPR119) agonists and are useful as for the treatment of diabetes and obesity. | 09-01-2011 |
| 20110195994 | Piperidinyl GPCR Agonists - Compounds of formula (I): or pharmaceutically acceptable salts thereof, are GPCR agonists and are useful as for the treatment of diabetes and obesity. | 08-11-2011 |
| 20110178054 | Heterocyclic GPCR Agonists - Compounds of formula (I): or pharmaceutically acceptable salts thereof, are GPCR (GPR119) agonists and are useful as for the treatment of diabetes and obesity. | 07-21-2011 |
| 20100093733 | AMIDE AND UREA DERIVATIVES FOR THE TREATMENT OF METABOLIC DISEASES - Compounds of formula (I): or pharmaceutically acceptable salts and esters thereof, are useful for the treatment of obesity, type II diabetes and the metabolic syndrome. | 04-15-2010 |
| 20090281060 | HETEROCYCLIC DERIVATIVES AS GPCR RECEPTOR AGONISTS - Compounds of Formula (I), R | 11-12-2009 |
